New Flagship startup aims to trailblaze ‘AI science factories’news2025-03-10T19:39:42+00:00March 10th, 2025|Endpoints News|
At $300M Kardigan startup, former MyoKardia team unveils its first drug, and it comes from Ionisnews2025-03-07T16:16:52+00:00March 7th, 2025|Endpoints News|
Longtime biotech investor Frazier Life Sciences is raising its latest venture fundnews2025-03-06T16:35:02+00:00March 6th, 2025|Endpoints News|
Lilly, Pfizer invest in Trimtech’s seed round for neurodegeneration protein degradersnews2025-03-05T16:28:54+00:00March 5th, 2025|Endpoints News|
Swiss biotech ends Phase 2 study in Alzheimer’s shortly after Lilly and Biogen did the samenews2025-03-04T16:01:49+00:00March 4th, 2025|Endpoints News|
Sofinnova Partners raises €1.2B to invest in life sciencesnews2025-03-04T07:00:17+00:00March 4th, 2025|Endpoints News|
Callio emerges with $187M and ADCs from a decade-old Singapore biotechnews2025-03-03T14:00:31+00:00March 3rd, 2025|Endpoints News|
BridgeBio oncology spinout to go public via combination with SPAC from Cormorant and Bihua Chennews2025-02-28T12:51:27+00:00February 28th, 2025|Endpoints News|
Pharma-backed Mission Therapeutics stops preclinical operations, focuses on two clinical assetsnews2025-02-27T19:23:21+00:00February 27th, 2025|Endpoints News|
Kallyope quietly reports Phase 2 obesity data, begins mid-stage migraine trialnews2025-02-27T11:11:16+00:00February 27th, 2025|Endpoints News|
